Quantiferon-TB Gold in the Assessment of Latent TB in Patients Candidate to Treatment or Treated With TNFα Antagonists (TNFTB)
Comparison of Quantiferon-TB Gold Assay With Tuberculin Skin Testing in the Assessment of Latent Mycobacterium Tuberculosis Infection in Patients Candidate to Treatment or Treated With TNFα Antagonists
Sponsor: ASST Fatebenefratelli Sacco
Listed as NCT00491933, this NA trial focuses on Rheumatoid Arthritis and Spondylarthritis and remains ongoing. Sponsored by ASST Fatebenefratelli Sacco, it has been updated 7 times since 2007, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.
Status Flow
Change History
7 versions recorded-
Sep 2025 — Present [monthly]
Unknown NA
-
Sep 2024 — Sep 2025 [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status NA
-
Jun 2018 — Jan 2021 [monthly]
Unknown Status NA
▶ Show 2 earlier versions
-
Sep 2017 — Jun 2018 [monthly]
Unknown Status NA
-
Jan 2017 — Sep 2017 [monthly]
Unknown Status NA
First recorded
Jun 2007
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- ASST Fatebenefratelli Sacco
For direct contact, visit the study record on ClinicalTrials.gov .